What if you could create a biotech startup focused on treating a rare disease, with a drug candidate already in…
Super UserApril 25, 2013
... Funding Opportunity Number: RFA-AR-14-008 Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement Category of Funding Activity: Health CFDA Number:…
Super UserApril 24, 2013
... Funding Opportunity Number: PAR-13-207 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: HealthIncome Security and Social…
Super UserApril 24, 2013
... Funding Opportunity Number: PAR-13-206 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: HealthIncome Security and Social…
Super UserApril 24, 2013
... Funding Opportunity Number: PAR-13-203 Opportunity Category: Discretionary Funding Instrument Type: Grant Category of Funding Activity: HealthIncome Security and Social…
Super UserApril 24, 2013
... Funding Opportunity Number: PAR-13-202 Opportunity Category: Discretionary Funding Instrument Type: Cooperative Agreement Category of Funding Activity: Consumer ProtectionHealth CFDA…
Super UserApril 24, 2013
MedImmune has acquired Ann Arbor-based AlphaCore Pharma, creating another exit for a local up-and-coming start-up. MedImmune, the global biologics research…
Super UserApril 24, 2013
The purpose of the NHLBI SBIR Phase IIB Bridge Award is to facilitate and accelerate the capital-intensive steps that are…
Super UserApril 24, 2013
In these changing times, the concept of Open Innovation is one that we at AstraZeneca have fully embraced. By sharing…
Super UserApril 24, 2013